197 related articles for article (PubMed ID: 23302892)
1. Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysis.
Berchtold S; Lampe J; Weiland T; Smirnow I; Schleicher S; Handgretinger R; Kopp HG; Reiser J; Stubenrauch F; Mayer N; Malek NP; Bitzer M; Lauer UM
J Virol; 2013 Mar; 87(6):3484-501. PubMed ID: 23302892
[TBL] [Abstract][Full Text] [Related]
2. A novel armed oncolytic measles vaccine virus for the treatment of cholangiocarcinoma.
Lange S; Lampe J; Bossow S; Zimmermann M; Neubert W; Bitzer M; Lauer UM
Hum Gene Ther; 2013 May; 24(5):554-64. PubMed ID: 23550539
[TBL] [Abstract][Full Text] [Related]
3. Primary resistance phenomena to oncolytic measles vaccine viruses.
Noll M; Berchtold S; Lampe J; Malek NP; Bitzer M; Lauer UM
Int J Oncol; 2013 Jul; 43(1):103-12. PubMed ID: 23612727
[TBL] [Abstract][Full Text] [Related]
4. Type 1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles Virus.
Aref S; Castleton AZ; Bailey K; Burt R; Dey A; Leongamornlert D; Mitchell RJ; Okasha D; Fielding AK
Mol Ther; 2020 Apr; 28(4):1043-1055. PubMed ID: 32087150
[TBL] [Abstract][Full Text] [Related]
5. Pulsed versus continuous application of the prodrug 5-fluorocytosine to enhance the oncolytic effectiveness of a measles vaccine virus armed with a suicide gene.
Yurttas C; Berchtold S; Malek NP; Bitzer M; Lauer UM
Hum Gene Ther Clin Dev; 2014 Jun; 25(2):85-96. PubMed ID: 24933569
[TBL] [Abstract][Full Text] [Related]
6. Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase.
Hartkopf AD; Bossow S; Lampe J; Zimmermann M; Taran FA; Wallwiener D; Fehm T; Bitzer M; Lauer UM
Gynecol Oncol; 2013 Aug; 130(2):362-8. PubMed ID: 23676551
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response.
Achard C; Boisgerault N; Delaunay T; Roulois D; Nedellec S; Royer PJ; Pain M; Combredet C; Mesel-Lemoine M; Cellerin L; Magnan A; Tangy F; Grégoire M; Fonteneau JF
Oncotarget; 2015 Dec; 6(42):44892-904. PubMed ID: 26539644
[TBL] [Abstract][Full Text] [Related]
8. Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis.
Westcott MM; Liu J; Rajani K; D'Agostino R; Lyles DS; Porosnicu M
J Virol; 2015 Aug; 89(15):7944-54. PubMed ID: 25995245
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Sensitivity of Neuroendocrine Neoplasms to an Armed Oncolytic Measles Vaccine Virus.
Scheicher NV; Berchtold S; Beil J; Smirnow I; Schenk A; Lauer UM
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339240
[TBL] [Abstract][Full Text] [Related]
10. Cell-cell fusion induced by measles virus amplifies the type I interferon response.
Herschke F; Plumet S; Duhen T; Azocar O; Druelle J; Laine D; Wild TF; Rabourdin-Combe C; Gerlier D; Valentin H
J Virol; 2007 Dec; 81(23):12859-71. PubMed ID: 17898060
[TBL] [Abstract][Full Text] [Related]
11. Vesicular stomatitis virus has extensive oncolytic activity against human sarcomas: rare resistance is overcome by blocking interferon pathways.
Paglino JC; van den Pol AN
J Virol; 2011 Sep; 85(18):9346-58. PubMed ID: 21734048
[TBL] [Abstract][Full Text] [Related]
12. Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine Virus.
Scheubeck G; Berchtold S; Smirnow I; Schenk A; Beil J; Lauer UM
Viruses; 2019 Jul; 11(7):. PubMed ID: 31284426
[TBL] [Abstract][Full Text] [Related]
13. An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis.
Lampe J; Bossow S; Weiland T; Smirnow I; Lehmann R; Neubert W; Bitzer M; Lauer UM
Gene Ther; 2013 Nov; 20(11):1033-41. PubMed ID: 23719065
[TBL] [Abstract][Full Text] [Related]
14. Measles virus suppresses interferon-alpha signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-alpha receptor complex.
Yokota S; Saito H; Kubota T; Yokosawa N; Amano K; Fujii N
Virology; 2003 Feb; 306(1):135-46. PubMed ID: 12620806
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome Analysis of Human Glioblastoma Cells Susceptible to Infection with the Leningrad-16 Vaccine Strain of Measles Virus.
Ammour Y; Susova O; Krasnov G; Nikolaeva E; Varachev V; Schetinina Y; Gavrilova M; Mitrofanov A; Poletaeva A; Bekyashev A; Faizuloev E; Zverev VV; Svitich OA; Nasedkina TV
Viruses; 2022 Nov; 14(11):. PubMed ID: 36366531
[TBL] [Abstract][Full Text] [Related]
16. IFIT1 Expression Patterns Induced by H9N2 Virus and Inactivated Viral Particle in Human Umbilical Vein Endothelial Cells and Bronchus Epithelial Cells.
Feng B; Zhang Q; Wang J; Dong H; Mu X; Hu G; Zhang T
Mol Cells; 2018 Apr; 41(4):271-281. PubMed ID: 29629559
[TBL] [Abstract][Full Text] [Related]
17. Double-stranded RNA induces biphasic STAT1 phosphorylation by both type I interferon (IFN)-dependent and type I IFN-independent pathways.
Dempoya J; Matsumiya T; Imaizumi T; Hayakari R; Xing F; Yoshida H; Okumura K; Satoh K
J Virol; 2012 Dec; 86(23):12760-9. PubMed ID: 22973045
[TBL] [Abstract][Full Text] [Related]
18. PACT- and RIG-I-Dependent Activation of Type I Interferon Production by a Defective Interfering RNA Derived from Measles Virus Vaccine.
Ho TH; Kew C; Lui PY; Chan CP; Satoh T; Akira S; Jin DY; Kok KH
J Virol; 2016 Feb; 90(3):1557-68. PubMed ID: 26608320
[TBL] [Abstract][Full Text] [Related]
19. Biological treatment of pediatric sarcomas by combined virotherapy and NK cell therapy.
Klose C; Berchtold S; Schmidt M; Beil J; Smirnow I; Venturelli S; Burkard M; Handgretinger R; Lauer UM
BMC Cancer; 2019 Dec; 19(1):1172. PubMed ID: 31795974
[TBL] [Abstract][Full Text] [Related]
20. A Three-Dimensional Organoid Model of Primary Breast Cancer to Investigate the Effects of Oncolytic Virotherapy.
Carter ME; Hartkopf AD; Wagner A; Volmer LL; Brucker SY; Berchtold S; Lauer UM; Koch A
Front Mol Biosci; 2022; 9():826302. PubMed ID: 35223990
[No Abstract] [Full Text] [Related]
[Next] [New Search]
